Lumida
/BLUE
⌘K
Genetix Biotherapeutics Inc

Genetix Biotherapeutics Inc

BLUE
$4.97USD+0.00%+0.00 today

MARKET CAP

48.7M

P/E (TTM)

FWD P/E

DAY RANGE

$5 – $5

52W RANGE

$3
$29
STATEMENT·Income statement
USD · GAAP
METRICFY 2020FY 2021FY 2022FY 2023FY 2024TREND
Sales, Adj.$0$3.7M$3.6M$29.5M$83.8M
YoY %-1.8%+720.0%+184.1%
P / Sales
EV / Sales
Gross Profit, Adj.$0$-35.2M$-6.5M$-4.0M$-5.6M
YoY %+81.6%+37.8%-38.3%
Margin %-961.1%-180.2%-13.7%-6.6%
EV / Gross Profit
EBITDA, Adj.$-539.9M$-545.5M$-338.9M$-308.7M$-206.5M
YoY %+1.0%-1.0%+37.9%+8.9%+33.1%
Margin %-14895.2%-9421.8%-1046.4%-246.3%
EV / EBITDA
EBIT$-559.3M$-590.9M$-352.2M$-337.2M$-270.5M
YoY %+0.7%-5.7%+40.4%+4.3%+19.8%
Margin %-16136.3%-9791.1%-1143.1%-322.7%
EV / EBIT
Net Income$-618.7M$-819.4M$-230.3M$-211.9M$-240.7M
YoY %+21.6%-32.4%+71.9%+8.0%-13.6%
Net Margin-22375.2%-6403.7%-718.4%-287.2%
EPS (GAAP)-$199.00-$237.80-$58.60-$38.59-$24.84
YoY %+30.5%-19.5%+75.4%+34.1%+35.6%